*Developing Countries Rate: Those qualifying for this rate must live in a country on the World Bank Developing Country List. To request this rate, email education@acmg.net with your name and country of residence to receive a discount code.

 ** Emeritus and Honorary Rate: To qualify for this rate, you must be an ACMG Emeritus member. To request this rate, email education@acmg.net to receive a discount code. If you are unsure of your membership status, email membership@acmg.net.

Purchases of the Digital Edition Only cannot be transferred to a meeting registration. If you purchase the Digital Edition Only and then decide to attend the meeting, you will need to email education@acmg.net  to request a refund for the Digital Edition Only. You will also need to register for the meeting separately. If you purchase registration and then decide to switch to the Digital Edition Only, you will need to cancel your registration by emailing acmgmeeting@acmg.net and purchase the Digital Edition Only separately. View the meeting registration cancellation policy here. 

ACMG Annual Clinical Genetics Meeting Digital Edition

Date of Release: April 21, 2025

Expiration Date: March 31, 2027

Credits offered: CME, P.A.C.E.®(Pending), NSGC (Pending)

Estimate time of completion: 71.25 hours

NSGC credit reports are sent annually (see reporting timeline below).

Course Description

The 2025 ACMG Annual Clinical Genetics Meeting Digital Edition will present both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions will focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

Learning Objectives

At the conclusion of this course, participants should be able to:

1. Describe the advances in genetic testing including prenatal and postnatal indications, gene panels, genome sequencing, interpretation, genetic counseling, and ethical and legal issues.
2. Review select rare and common genetic disorders, from developmental disabilities to cancer predisposition syndromes, as well as novel therapeutic approaches including gene therapy.
3. Review select inborn errors of metabolism, approaches to their diagnoses and treatment, new disorders on the recommended newborn screening panel.
4. Recognize the importance of diversity, equity, and inclusion in clinical genetic care and research, and that inclusion is an essential component for the genetic workforce development.
5. Analyze the need for innovation and new approaches to transforming the current practice of genetic medicine to achieve a vision of genomically-informed precision population health.

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment, and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting is targeted for the following professionals:

• Medical and clinical geneticists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for patients with, or at risk for, genetically influenced health problems.
• Laboratory directors and technicians who conduct genetic testing.
• Researchers involved in the discovery of genetic disorders and treatments.
• Clinical, laboratory and research trainees of genetics and all biomedical sciences.
• Any healthcare and public health professionals who have an interest in medical and clinical genetics and genomics.
• Advocates for patients with genetic conditions and their families.

CME AMA PRA Category 1 Credits^TM, ASCLS P.A.C.E.®, NSGC

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 71.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

ASCLS P.A.C.E.® CEU's 

Approval for PACE contact hours is currently pending.

National Society of Genetic Counselors (NSGC):

This event has been submitted to the National Society of Genetic Counselors (NSGC) for approval of Category 1 CEUs. The American Board of Genetic Counseling (ABGC) accepts CEUs approved by NSGC for purposes of recertification. Approval for the requested CEUs and contact hours is currently pending.

ACMG reports completed accredited sessions to NSGC for credit certificates annually.

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

Participation Instructions (OnDemand)

1. Complete session by watching recordings.
2. Pass a post-test with a score of 80% or better (Learning mode activated and reset available).
3. Complete session evaluations

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.

*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships listed have been mitigated.

Financial Disclosures